Alvotech : publishes prospectus associated to the admission to buying and selling and itemizing on Nasdaq Iceland Main Market

0
60

Reference is made to the announcement issued on December 2, 2022 confirming that Nasdaq Iceland has authorised Alvotech S.A’s (“Alvotech”) request for admission to buying and selling of its shares on the Nasdaq Iceland Main Market (“Main Market”), pending passporting of the prospectus to Iceland.

The prospectus has now been authorised by the Commission de Surveillance du Secteur Financier, 283 route d’Arion, L2991 Luxembourg (“CSSF”) and passported to Iceland. It is accessible on Alvotech’s web site at https://buyers.alvotech.com/prospectus.

Nasdaq Iceland will announce the primary day of buying and selling with at the very least at some point advance discover.

Landsbankinn Corporate Banking offered course of oversight for the switch of the itemizing of Alvotech’s shares to the Main Market and admission to buying and selling.

Alvotech Investor Relations and Global Communication
Benedikt Stefansson
alvotech.ir[at]alvotech.com

Disclaimer

Alvotech SA revealed this content material on 06 December 2022 and is solely liable for the knowledge contained therein. Distributed by Public, unedited and unaltered, on 06 December 2022 09:01:03 UTC.

LEAVE A REPLY

Please enter your comment!
Please enter your name here